The DOI matches its Crossref record; the references it cites are not checked yet.
Combined metabolomics and proteomics reveals hypoxia as a cause of lower productivity on scale-up to a 5000-liter CHO bioprocess
Abstract
Large-scale bioprocessing is key to the successful manufacturing of a biopharmaceutical. However, cell viability and productivity are often lower in the scale-up from laboratory to production. In this study, we analyzed CHO cells, which showed lower percent viabilities and productivity in a 5-KL production scale bioreactor compared to a 20-L bench-top scale under seemingly identical process parameters. An increase in copper concentration in the media from 0.02 µM to 0.4 µM led to a doubling of percent viability in the production scale albeit still at a lower level than the bench-top scale. Combined metabolomics and proteomics revealed the increased copper reduced the presence of reactive oxygen species (ROS) in the 5-KL scale process. The reduction in oxidative stress was supported by the increased level of glutathione peroxidase in the lower copper level condition. The excess ROS was shown to be due to hypoxia (intermittent), as evidenced by the reduction in fibronectin with increased copper. The 20-L scale showed much less hypoxia and thus less excess ROS generation, resulting in little to no impact to productivity with the increased copper in the media. The study illustrates the power of 'Omics in aiding in the understanding of biological processes in biopharmaceutical production.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the mAb production performance under large-scale bioreactor was not desirable due to the lower cell viability and productivity (Gao et al., 2016; Vodopivec et al., 2019).”
From Enhancing and stabilizing monoclonal antibody production by Chinese hamster ovary (CHO) cells with optimized perfusion culture strategies (2023) · cites this paper as Gao et al., 2016
Citations
The citation lists haven’t been fetched yet
References 59 · Cited by 76
Research works printed but not linked: 1
- 10.1074/jbc.M110.217216 · DOI
Metadata
- Authors
- Gao, Y., Ray, S., Dai, S., Ivanov, A. R., Abu‐Absi, N. R., Lewis, A. M., Huang, Z., Xing, Z., Borys, M. C., Li, Z. J., & Karger, B. L.
- Affiliations
- Northeastern University (US)
- Bristol-Myers Squibb (United States) (US)
- Corresponding author
- Karger, Barry L.
- ORCID
- Venue
- Biotechnology Journal
- Publisher
- Wiley
- Published
- 2016-06-29
- Volume
- 11
- Issue
- 9
- Pages
- 1190-1200
- ISSN
- 1860-6768 (ISSN-L)
- 1860-7314
- OpenAlex
- W2401202998
- Cited by
- 76
- References
- 59
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 8 · 2023: 9 · 2022: 4 · 2021: 11 · 2020: 9 · 2019: 5 · 2018: 12 · 2017: 6 · 2016: 1
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biotechnology Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Physical Sciences › Chemical Engineering › Fluid Flow and Transfer Processes › Fluid Dynamics and Mixing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Keywords
- CHO cells, hypoxia, scale-up, biopharmaceutical manufacturing, copper content, reactive oxygen species, oxidative stress, glutathione peroxidase, fibronectin, cell viability, metabolomics, proteomics
- MeSH terms
- Animals, Cell Survival, Copper, Cricetulus, Fibronectins, Humans, Cell Hypoxia, CHO Cells, Reactive Oxygen Species, Bioreactors, Proteomics, Cell Proliferation, Metabolomics, Batch Cell Culture Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Combined metabolomics and proteomics reveals hypoxia as a cause of lower productivity on scale-up to a 5000-liter CHO bioprocess. https://app.cochat.ai/papers/10.1002/biot.201600030
- The paper
- Gao, Y., Ray, S., Dai, S., Ivanov, A. R., Abu‐Absi, N. R., Lewis, A. M., Huang, Z., Xing, Z., Borys, M. C., Li, Z. J., & Karger, B. L. (2016). Combined metabolomics and proteomics reveals hypoxia as a cause of lower productivity on scale-up to a 5000-liter CHO bioprocess. Biotechnology Journal. https://doi.org/10.1002/biot.201600030
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.